<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">03180</article-id><article-id pub-id-type="doi">10.7554/eLife.03180</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology</subject></subj-group></article-categories><title-group><article-title>CD28 expression is required after T cell priming for helper T cell responses and protective immunity to infection</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-10878"><name><surname>Linterman</surname><given-names>Michelle A</given-names></name><aff><addr-line><named-content content-type="department">Lymphocyte Signalling and Development</named-content></addr-line>, <institution>Babraham Institute</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country><email>Michelle.Linterman@babraham.ac.uk</email></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10535"><name><surname>Denton</surname><given-names>Alice E</given-names></name><aff><addr-line><named-content content-type="department">CRUK Cambridge Institute</named-content></addr-line>, <institution>University of Cambridge</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13844"><name><surname>Divekar</surname><given-names>Devina P</given-names></name><aff><addr-line><named-content content-type="department">Biomedical Research Centre, School of Biological Sciences</named-content></addr-line>, <institution>University of East Anglia</institution>, <addr-line><named-content content-type="city">Norwich</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13847"><name><surname>Zvetkova</surname><given-names>Ilona</given-names></name><aff><addr-line><named-content content-type="department">Institute of Metabolic Science, Addenbrooke's Hospital</named-content></addr-line>, <institution>University of Cambridge Metabolic Research Laboratories</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13845"><name><surname>Kane</surname><given-names>Leanne</given-names></name><aff><addr-line><named-content content-type="department">Wellcome Trust Genome Campus</named-content></addr-line>, <institution>Wellcome Trust Sanger Institute</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18260"><name><surname>Ferreira</surname><given-names>Cristina</given-names></name><aff><addr-line><named-content content-type="department">Babraham Research Campus</named-content></addr-line>, <institution>Babraham Institute</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18261"><name><surname>Veldhoen</surname><given-names>Marc</given-names></name><aff><addr-line><named-content content-type="department">Babraham Research Campus</named-content></addr-line>, <institution>Babraham Institute</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13846"><name><surname>Clare</surname><given-names>Simon</given-names></name><aff><addr-line><named-content content-type="department">Wellcome Trust Genome Campus</named-content></addr-line>, <institution>Wellcome Trust Sanger Institute</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13703"><name><surname>Dougan</surname><given-names>Gordon</given-names></name><aff><addr-line><named-content content-type="department">Wellcome Trust Genome Campus</named-content></addr-line>, <institution>Wellcome Trust Sanger Institute</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20847"><name><surname>Espéli</surname><given-names>Marion</given-names></name><aff><institution>UMR-S996, LabEx LERMIT</institution>, <addr-line><named-content content-type="city">Clamart</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13849"><name><surname>Smith</surname><given-names>Kenneth G C</given-names></name><aff><addr-line><named-content content-type="department">Cambridge Institute for Medical Research</named-content></addr-line>, <institution>University of Cambridge School of Clinical Medicine</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1164"><name><surname>Powrie</surname><given-names>Fiona M</given-names></name><role>Reviewing editor</role><aff><institution>Oxford University</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>10</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e03180</elocation-id><supplementary-material><ext-link xlink:href="elife-03180-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>29</day><month>04</month><year>2014</year></date><date date-type="accepted"><day>24</day><month>10</month><year>2014</year></date></history><permissions><copyright-statement>Copyright © 2014, Linterman et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Linterman et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>The costimulatory molecule CD28 is essential for activation of helper T cells. Despite this critical role, it is not known whether CD28 has functions in maintaining T cell responses following activation.  To determine the role for CD28 after T cell priming we generated a strain of mice where CD28 is removed from CD4<sup>+</sup> T cells after priming. We show that continued CD28 expression is important for effector CD4<sup>+</sup> T cells following infection; maintained CD28 is required for the expansion of T helper type 1 cells, and for the differentiation and maintenance of T follicular helper cells during viral infection. Persistent CD28 is also required for clearance of the bacterium <italic>Citrobacter rodentium</italic> from the gastrointestinal tract.  Together, this study demonstrates that CD28 persistence is required for helper T cell polarization in response to infection, describing a novel function for CD28 that is distinct from its role in T cell priming.</p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author keywords</title><kwd>CD28</kwd><kwd>helper T cells</kwd><kwd>infection</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All experiments were performed according to the regulations of the UK Home Office Scientific Procedures Act (1986) under the UK Home Office license PPL 80/2438, or PPL 80/2596.</p></fn></fn-group></back></article>